Latest News
The Insight 46 study has indicated that changes in blood pressure in people as young as 36 may be linked to poorer brain health later in life.
Analysis of large Danish and American datasets suggests that poor air quality may increase the prevalence of neurological and psychiatric disorders.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
Journal Articles
Discover more about an ongoing, multicenter registry that provides real-world evidence regarding ataluren use in nonsense mutation Duchenne muscular dystrophy patients in this research article.
In this Editorial, published in the journal Future Neurology, the author discusses the need for continued funding for spinal muscular atrophy.
In this review article, published in the journal Immunotherapy, the authors explore immunotherapy for neuroblastoma from therapeutic backbone to the latest discoveries.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
Blood pressure changes in mid-30s linked to poorer brain health
Age-related cognitive changes may be reduced with intensive blood pressure control
Hypertension drug increases cerebral blood flow in people with Alzheimer’s, study suggests
CNS/PNS/SNS
Nerve transfer surgery restores hand and arm function
EAN 2019: Neural clock and internal ‘GPS’ may provide valuable insights into Alzheimer’s disease
New technology generates synthetic speech using brain activity
Cognitive/neurodegenerative disorders
Blood pressure changes in mid-30s linked to poorer brain health
A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
Age-related cognitive changes may be reduced with intensive blood pressure control
Demyelinating disease
‘Smoldering’ spots: a hallmark for progressive multiple sclerosis?
Could MRI scans predict the disease progression of multiple sclerosis?
Development and pediatrics
Exosomes: the key to treating and diagnosing neurodevelopmental disorders?
Spinraza®: positive long-term data reported in pre-symptomatic infants
Epilepsy and seizure
Genetics
A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
Advances in migraine genetics, neurobiology and treatment
Early-onset Alzheimer’s disease linked to high LDL cholesterol levels
Headache
Emgality® achieves primary and secondary outcomes in Phase III trial for migraines
Acute migraine: novel therapy shows promise in Phase III trial
Why are migraines more common in women? New sex-specific insights revealed
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
Could a bacterial polysaccharide suppress fatal brain inflammation?
Link between Alzheimer’s disease and periodontal bacteria gains traction
Injury/trauma
Nerve transfer surgery restores hand and arm function
Can inflammatory biomarkers predict recovery time after concussion?
Movement disorders
Study reveals the potential role of α-synuclein in DNA repair as a new target for Parkinson’s
Neuro-ophthalmology
Gene therapy breakthrough allows mice to regain sight
Could an eye scan detect signs of Alzheimer's disease?
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
Neuropsychiatry
Could psychiatric disorders be triggered by air pollution?
Addiction: a compulsive interplay between drugs, cues and habits
Galanin identified as new therapeutic target for the treatment of depression
Oncology/tumor
Glioblastoma: could a blood test be on the horizon?
Veledimex: a drug-inducible gene therapy approach for glioblastoma yields promising Phase I results
Risk of Alzheimer’s may be raised by hormone therapy for prostate cancer
Pain
Emgality® achieves primary and secondary outcomes in Phase III trial for migraines
Advances in migraine genetics, neurobiology and treatment
Acute migraine: novel therapy shows promise in Phase III trial
Sleep
Acute light exposure at night doesn’t affect circadian rhythm in mice, research suggests
AAIC 2019: Sleep medications may increase dementia risk depending on race and gender
AAIC 2019: How can sleep disruption be improved in individuals with dementia?
